Calcium folinate pentahydrate
Rectal Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen UniversitySmall moleculePhase 3Active
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 67/ 100
- Competitive Position
- 73/ 100
Competitive context
36 Active assets in the Rectal Adenocarcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM Sixth Affiliated Hospital, Sun Yat-sen University | Phase 3 | BBB |
Eloxatin Sixth Affiliated Hospital, Sun Yat-sen University | Phase 3 | BB |
METRONIDAZOLE AC Camargo Cancer Center | Phase 4 | B |
Capecitabine Chongqing University Cancer Hospital | Phase 3 | B |
Pucotenlimab Sun Yat-sen University | Phase 3 | B |
View all 45 →
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →